S&P 500$7,553.68
-0.74%
2m
DOW 30$50,687.07
-1.21%
2m
NASDAQ 100$30,571.24
-0.29%
2m
Russell 2000$287.67
-1.37%
2m
Russell 1000$411.83
-0.71%
2m
S&P 400$3,751.11
-0.10%
2m
S&P 600$1,681.95
-0.85%
2m

JOURNEY MEDICAL (DERM)

NASDAQ

$6.06-$0.005 (-0.08%)

Price as of Jun 03, 2026 6:57 PM EDT

$135.9M
Market Cap
-18.66%
1-Year Change
Drug Manufacturers - Specialty & Generic
Industry

Annual

Quarterly

	12/31/2025	12/31/2024	12/31/2023	12/31/2022
Income Statement
Total Operating Revenue	61.9M +10.20%	56.1M -29.11%	79.2M +7.48%	73.7M +16.69%
Cost of Revenue	20.9M +0.22%	20.9M -21.68%	26.7M -13.37%	30.8M -4.08%
Gross Profit	40.9M +16.11%	35.3M -32.87%	52.5M +22.44%	42.9M +38.14%
Sales and Marketing Expense	44.4M +10.36%	40.2M -8.44%	43.9M -26.16%	59.5M +49.29%
Research and Development Expense	-480,000 -95.13%	-9.9M +30.71%	-7.5M -31.09%	-10.9M +299.53%
Depreciation and Amortization Expense	4.3M +24.36%	3.4M -9.11%	3.8M -11.92%	4.3M +72.88%
Total Operating Expenses	70.0M +0.31%	69.8M -14.08%	81.3M -19.70%	101.2M +3.24%
Operating Profit	-8.2M -40.25%	-13.7M +559.77%	-2.1M -92.47%	-27.5M -21.11%
Interest Income	589,000 -22.19%	757,000 +135.09%	322,000 +436.67%	60,000 +2,900.00%
Interest Expense	-3.7M +54.53%	-2.4M +40.93%	-1.7M -15.90%	-2.0M -71.30%
Interest Income and Expense and Net	-3.1M +90.04%	-1.6M +18.90%	-1.4M -29.76%	-2.0M -72.14%
Total Nonoperating Income and Expense	-3.2M +242.51%	-934,000 -40.09%	-1.6M -23.88%	-2.0M -72.62%
Income before Taxes	-11.4M -22.18%	-14.6M +302.29%	-3.6M -87.72%	-29.6M -30.21%
Income Taxes	60,000 -1.64%	61,000 -72.40%	221,000 +250.79%	63,000 -96.14%
Extraordinary Items	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Net Income	-11.4M -22.09%	-14.7M +280.79%	-3.9M -87.00%	-29.6M -32.65%
Net Income from Continuing Operations Applicable to Common	-11.4M -22.18%	-14.6M +302.29%	-3.6M -87.72%	-29.6M -30.21%
Basic EPS and Net Income	-0.47 -34.72%	-0.72 +242.86%	-0.21 -87.57%	-1.69 -60.88%
Diluted EPS and Net Income	-0.47 -34.72%	-0.72 +242.86%	-0.21 -87.57%	-1.69 -60.88%
Basic Weighted Average Shares	24.5M +19.90%	20.4M +12.06%	18.2M +4.00%	17.5M +72.05%
Diluted Weighted Average Shares	24.5M +19.90%	20.4M +12.06%	18.2M +4.00%	17.5M +72.05%
Balance Sheet
Cash and Cash Equivalents	24.1M +18.64%	20.3M -26.00%	27.4M -14.26%	32.0M -34.80%
Short-Term Investments	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Cash and Cash Equivalents and Short-Term Investments	24.1M +18.64%	20.3M -26.00%	27.4M -14.26%	32.0M -34.80%
Total Current Assets	66.9M +38.80%	48.2M -14.66%	56.5M -27.32%	77.7M -8.06%
Accumulated Depreciation	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Property and Plant and Equipment and Net	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Total Long-Term Assets	N/A N/A	6,000 0.00%	6,000 -93.68%	95,000 -36.67%
Total Assets	94.6M +17.88%	80.2M +4.41%	76.8M -26.92%	105.2M +8.10%
Income Taxes Payable	70,000 +16.67%	60,000 +13.21%	53,000 +51.43%	35,000 +337.50%
Total Short-Term Debt	N/A N/A	N/A N/A	2.9M 0.00%	2.9M +263.05%
Total Current Liabilities	37.4M +6.44%	35.2M -15.99%	41.9M -37.35%	66.8M +29.50%
Total Long-Term Debt	25.3M +1.60%	24.9M +70.15%	14.6M -26.25%	19.8M +279.81%
Total Long-Term Liabilities	25.3M +1.19%	25.0M +70.85%	14.6M -26.60%	19.9M +20,450.52%
Total Liabilities	62.7M +4.26%	60.2M +6.50%	56.5M -35.93%	88.2M +59.62%
Retained Earnings	-98.5M +13.14%	-87.0M +20.28%	-72.4M +5.62%	-68.5M +76.22%
Total Stockholders Equity	31.9M +58.71%	20.1M -1.38%	20.4M +19.83%	17.0M -59.61%
Total Shares Outstanding	21.1M +252.41%	6.0M -68.95%	19.3M +8.77%	17.8M +2.59%
Cash Flow
Cash from Operating Activities	-12.4M +36.31%	-9.1M -274.18%	5.2M +138.72%	-13.5M +520.54%
Capital Expenditures	15.0M 0.00%	15.0M +200.00%	5.0M -75.00%	20.0M N/A
Cash from Investing Activities	-15.0M 0.00%	-15.0M +200.00%	-5.0M -75.00%	-20.0M +100.00%
Dividends Paid	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Cash from Financing Activities	16.2M -4.51%	17.0M +453.73%	-4.8M -129.19%	16.5M -68.96%
Financials Ratio
Gross Margin	66.17% +5.36%	62.81% -5.31%	66.33% +13.92%	58.23% N/A
Operating Margin	-13.21% -45.78%	-24.36% +830.63%	-2.62% -92.99%	-37.35% N/A
Return on Assets	-13.08% -30.00%	-18.68% +341.19%	-4.23% -85.54%	-29.27% N/A
Return on Equity	-44.03% -39.35%	-72.60% +251.71%	-20.64% -79.44%	-100.39% N/A
Revenue Growth	10.20% +135.03%	-29.11% -489.02%	7.48% -55.16%	16.69% N/A
Current Ratio	1.79 +30.39%	1.37 +1.58%	1.35 +16.01%	1.16 N/A
Cash Ratio	0.64 +11.45%	0.58 -11.92%	0.66 +36.86%	0.48 N/A
Debt-to-Equity Ratio	N/A N/A	N/A N/A	0.86 -35.62%	1.34 N/A
Debt-to-Assets Ratio	N/A N/A	N/A N/A	0.23 +5.54%	0.22 N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow